JP2010522762A - 糖尿病の治療のための方法及びプロブコール誘導体の組成物 - Google Patents

糖尿病の治療のための方法及びプロブコール誘導体の組成物 Download PDF

Info

Publication number
JP2010522762A
JP2010522762A JP2010501185A JP2010501185A JP2010522762A JP 2010522762 A JP2010522762 A JP 2010522762A JP 2010501185 A JP2010501185 A JP 2010501185A JP 2010501185 A JP2010501185 A JP 2010501185A JP 2010522762 A JP2010522762 A JP 2010522762A
Authority
JP
Japan
Prior art keywords
substituted
alkyl
diabetes
butyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010501185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010522762A5 (https=
Inventor
スコツト，ロバート・エイ・デイー
Original Assignee
サルトリア・フアーマシユーテイカルズ・エル・エル・シー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サルトリア・フアーマシユーテイカルズ・エル・エル・シー filed Critical サルトリア・フアーマシユーテイカルズ・エル・エル・シー
Publication of JP2010522762A publication Critical patent/JP2010522762A/ja
Publication of JP2010522762A5 publication Critical patent/JP2010522762A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2010501185A 2007-03-26 2008-03-26 糖尿病の治療のための方法及びプロブコール誘導体の組成物 Pending JP2010522762A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92009907P 2007-03-26 2007-03-26
PCT/US2008/058245 WO2008118948A1 (en) 2007-03-26 2008-03-26 Methods and compositions of derivatives of probucol for the treatment of diabetes

Publications (2)

Publication Number Publication Date
JP2010522762A true JP2010522762A (ja) 2010-07-08
JP2010522762A5 JP2010522762A5 (https=) 2012-05-10

Family

ID=39789010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010501185A Pending JP2010522762A (ja) 2007-03-26 2008-03-26 糖尿病の治療のための方法及びプロブコール誘導体の組成物

Country Status (9)

Country Link
US (2) US8252840B2 (https=)
EP (1) EP2139320A4 (https=)
JP (1) JP2010522762A (https=)
CN (1) CN101686676A (https=)
AU (1) AU2008230861A1 (https=)
BR (1) BRPI0809423A2 (https=)
CA (1) CA2682258A1 (https=)
IL (1) IL201119A0 (https=)
WO (1) WO2008118948A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021512879A (ja) * 2018-01-30 2021-05-20 デモテック．インコーポレイテッド プロブコール誘導体及びその調製方法と使用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011058193A1 (en) 2009-11-16 2011-05-19 Mellitech [1,5]-diazocin derivatives
US20160039877A1 (en) * 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
WO2015155238A1 (en) * 2014-04-08 2015-10-15 Neurovive Pharmaceutical Ab Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex i-related impairment of mitochondrial oxidative phosphorylation
TR201810411T4 (tr) 2014-04-08 2018-08-27 Neurovive Pharmaceutical Ab Özgün hücre geçirgen süksinat bileşikleri.
US20240259650A1 (en) * 2023-01-27 2024-08-01 Netflix, Inc. Systems and methods for pausing a digital media stream in response to determining that an associated display device is turned off

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514344A (ja) * 2001-10-25 2005-05-19 アセロジエニクス・インコーポレイテツド 移植拒絶治療のための化合物と方法
WO2005112914A2 (en) * 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
WO2006007508A2 (en) * 2004-07-01 2006-01-19 Atherogenics, Inc. Compounds and methods for treating diabetic vascular diseases

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179701A (en) 1962-05-14 1965-04-20 Shell Oil Co (3, 5-dialkyl-4-hydroxyphenyl) (3, 5-dialkyl-4-hydroxybenzyl) sulfides
US4115590A (en) 1964-02-26 1978-09-19 Ethyl Corporation Binuclear phenols for reducing plasma lipid levels
GB1136539A (en) 1966-12-13 1968-12-11 Uniroyal Inc Phenolic sulphides
GB1199871A (en) 1967-05-11 1970-07-22 Consolidation Coal Co Improvements in or relating to Sulfur-Containing Bisphenols
GB1148550A (en) 1967-12-02 1969-04-16 Uniroyal Inc Substituted benzylphenyl sulfides and their use as antioxidants
US3479407A (en) 1968-11-06 1969-11-18 Consolidation Coal Co Sulfurization of 2,6-di-tert-butylphenol
US3576883A (en) 1969-06-30 1971-04-27 Consolidation Coal Co Alkylidenedithiobisphenols
FR2130975A5 (en) 1971-03-29 1972-11-10 Aries Robert Bis(4-(phenoxyalkanoyloxy)-phenylthio)alkanes - hypolipemics hypocholesterolemics
FR2133024A5 (en) 1971-04-06 1972-11-24 Aries Robert Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity
FR2134810A5 (en) 1971-04-21 1972-12-08 Aries Robert Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity
FR2140771A5 (en) 1971-06-07 1973-01-19 Aries Robert Tetralinyl phenoxy alkanoic esters - of bis hydroxyphenylthio alkanes, hypolipemics etc
FR2140769A5 (en) 1971-06-07 1973-01-19 Aries Robert Benzofuryloxy alkanoic derivs of probucol - hypocholesterolemic and hypolipemic agents
FR2168137A1 (en) 1972-01-17 1973-08-31 Dynachim Sarl Bis 4-hydroxyphenylthioalkane esters - with hypocholesterolaemic and hypolipaemic activities
JPS4975552A (https=) 1972-11-20 1974-07-20
US3952064A (en) 1973-03-12 1976-04-20 Crown Zellerbach Corporation Process for producing mercaptophenols
US4029812A (en) 1976-02-18 1977-06-14 The Dow Chemical Company Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
JPS52125170A (en) 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU584669B2 (en) 1985-02-04 1989-06-01 G.D. Searle & Co. Novel disubstituted 4-hydroxyphenylthio anilides
US4755524A (en) 1986-01-31 1988-07-05 G. D. Searle & Co. Novel phenolic thioethers as inhibitors of 5-lipoxygenase
DE3625279A1 (de) 1986-07-25 1988-02-04 Merrell Dow Pharma Verwendung von probucol zur vorbeugung und behandlung von erkrankungen des herzens
US4975467A (en) 1987-03-17 1990-12-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions
ES2039489T3 (es) 1987-03-17 1993-10-01 Merrell Dow Pharmaceuticals Inc. La utilizacion del compuesto alquilidenditio-bis-(substituidos)-fenoles sustituidos.
US4752616A (en) 1987-06-29 1988-06-21 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use
US4968710A (en) 1987-11-13 1990-11-06 Riker Laboratories, Inc. Substituted di-t-butylphenols and anti-allergic use thereof
NZ226621A (en) 1987-11-13 1991-12-23 Riker Laboratories Inc Di-tert butyl phenols substituted by alkoxy, benzyloxy, or benzylthio groups; pharmaceutical compositions containing them
US5066822A (en) 1987-11-13 1991-11-19 Riker Laboratories, Inc Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
CH675422A5 (https=) 1988-03-31 1990-09-28 Symphar Sa
JP2754039B2 (ja) 1988-06-24 1998-05-20 塩野義製薬株式会社 ジ―ｔｅｒｔ―ブチルヒドロキシフェニルチオ誘導体
JP2627003B2 (ja) 1989-01-25 1997-07-02 塩野義製薬株式会社 ジーｔｅｒｔ―ブチルヒドロキシフェニルチオ誘導体
US5527945A (en) 1989-02-10 1996-06-18 Basf Aktiengesellschaft Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom
JP3065636B2 (ja) 1989-06-29 2000-07-17 塩野義製薬株式会社 ［ジ―ｔｅｒｔ―ブチル（ヒドロキシ）フェニルチオ］置換ヒドロキサム酸誘導体
DE3929913A1 (de) 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
US5061734A (en) 1990-05-09 1991-10-29 Merrell Dow Pharmaceuticals Inc. Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
US5112870A (en) 1990-05-09 1992-05-12 Merrell Dow Pharmaceuticals Inc. Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
US5155250A (en) 1990-07-05 1992-10-13 Merrell Dow Pharmaceuticals Inc. 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents
FR2666583B1 (fr) 1990-09-06 1994-09-09 Adir Nouveaux derives du spiro [4.5] decane, leur procede de preparation et leurs compositions pharmaceutiques les renfermant.
US5278014A (en) 1991-06-21 1994-01-11 Konica Corporation Electrophotographic photoreceptor
GB9115951D0 (en) 1991-07-24 1991-09-11 Pfizer Ltd Indoles
CA2427890A1 (en) 1992-02-05 1993-08-19 Ralf Anderskewitz New amidine derivatives, the preparation and use thereof
US5262439A (en) 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
US5310949A (en) 1992-09-02 1994-05-10 Merck & Co., Inc. Cholesterol lowering compounds
GB9220571D0 (en) 1992-09-30 1992-11-11 Ici Plc Quinazoline derivatives
US5821260A (en) 1992-10-30 1998-10-13 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5380747A (en) 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5807884A (en) 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
FR2704224B1 (fr) 1993-04-20 1995-08-25 Adir Nouveaux acides et esters phénoxy isobutyriques substitués.
JPH06312978A (ja) 1993-04-30 1994-11-08 Japan Tobacco Inc ホスホリパーゼａ２阻害活性を有する新規フタルイミド誘導体
US5411741A (en) 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
GB9320113D0 (en) 1993-09-29 1993-11-17 Zeneca Ltd Tricyclic derivatives
DE69434720T2 (de) 1993-12-10 2007-05-16 Aventis Inc. Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom
US5426196A (en) 1993-12-22 1995-06-20 Glaxo Inc. Synthesis of diaryl methanes
JPH07328425A (ja) 1994-06-03 1995-12-19 Toshiba Corp プラズマ化学反応装置
US5693337A (en) 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
US5635514A (en) 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors
GB9426103D0 (en) 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents
US5792787A (en) 1995-06-07 1998-08-11 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
JPH0959258A (ja) 1995-08-11 1997-03-04 Ono Pharmaceut Co Ltd グアニジル誘導体
FR2738817B1 (fr) 1995-09-14 1997-10-17 Adir Nouveaux acides et esters 2,2-dimethyl-omega-phenoxy alcanoiques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1997015546A1 (fr) 1995-10-26 1997-05-01 Nippon Shinyaku Co., Ltd. Derives d'acide carboxylique et compositions pharmaceutiques
MY117098A (en) 1996-01-15 2004-05-31 Janssen Pharmaceutica Nv Angiogenesis inhibiting pyridazinamines
WO1997028149A1 (en) 1996-02-02 1997-08-07 Merck & Co., Inc. Method for raising hdl cholesterol levels
US5608095A (en) 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
WO1997048694A1 (en) 1996-06-20 1997-12-24 Board Of Regents, The University Of Texas System Compounds and methods for providing pharmacologically active preparations and uses thereof
KR100648118B1 (ko) 1996-11-20 2006-11-28 아벤티스 파마슈티칼스 인크. 항산화제로서 유용한 치환 페놀 및 티오페놀
GB9705502D0 (en) 1997-03-17 1997-05-07 Univ Wales Swansea The Chlorination or aromatic compounds and catalysts therefor
CN1275596C (zh) 1997-05-14 2006-09-20 阿特罗吉尼克斯公司 普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US5954514A (en) * 1997-08-14 1999-09-21 Eastman Kodak Company Talking album for photographic prints
US6274603B1 (en) 1997-09-24 2001-08-14 Mcgill University Methods for increasing ApoE levels for the treatment of neurodegenerative disease
WO1999024400A1 (en) 1997-11-10 1999-05-20 Vyrex Corporation Probucol esters and uses thereof
FR2785284B1 (fr) 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
DE19850532A1 (de) 1998-11-03 2000-05-04 Nematel Dr Rudolf Eidenschink Bisphenylthio-Verbindungen
JP2002529740A (ja) 1998-11-09 2002-09-10 アセロジエニクス・インコーポレイテツド 血漿コレステロールレベルを低下させるための方法及び組成物
TR200101425T2 (tr) 1998-11-23 2002-02-21 Janssen Pharmaceutica N.V. IL-5 inhibe edici 6-azaurasil türevleri
CN1660840A (zh) 1999-03-30 2005-08-31 诺瓦提斯公司 治疗炎性疾病的酞嗪衍生物
CA2403823A1 (en) 2000-03-21 2001-09-27 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of vcam-1
EP1282445A2 (en) 2000-03-21 2003-02-12 Atherogenics, Inc. N-substituted dithiocarbamates for the treatment of biological disorders
US6323359B1 (en) 2000-05-02 2001-11-27 Salsbury Chemicals, Inc. Process for preparing probucol derivatives
US20030064967A1 (en) 2001-04-11 2003-04-03 Jayraz Luchoomun Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters
AU2002352826B2 (en) * 2001-11-09 2009-05-28 Atherogenics, Inc. Methods of reversing and preventing cardiovascular pathologies
US7187870B2 (en) 2003-10-15 2007-03-06 Oewaves, Inc. Tunable balanced opto-electronic filters and applications in opto-electronic oscillators
EP2651494B1 (en) 2010-12-13 2017-02-15 Pacesetter, Inc. Delivery catheter

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514344A (ja) * 2001-10-25 2005-05-19 アセロジエニクス・インコーポレイテツド 移植拒絶治療のための化合物と方法
WO2005112914A2 (en) * 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
WO2006007508A2 (en) * 2004-07-01 2006-01-19 Atherogenics, Inc. Compounds and methods for treating diabetic vascular diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6013008214; Ｓｈｉｎ-ｉｃｈｉ　Ｇｏｒｏｇａｗａ　ｅｔ　ａｌ: Ｄｉａｂｅｔｅｓ　Ｒｅｓｅａｒｃｈ　ａｎｄ　Ｃｌｉｎｉｃａｌ　Ｐｒａｃｔｉｃｅ ５７（１）, 20020701, ｐ．１-１０ *
JPN6013008217; Ｃｈａｒｌｅｓ　Ｑ．　Ｍｅｎｇ　ｅｔ　ａｌ: Ｂｉｏｏｒｇａｎｉｃ　＆　Ｍｅｄｉｃｉｎａｌ　Ｃｈｅｍｉｓｔｒｙ　Ｌｅｔｔｅｒｓ １２（１８）, 200201, ｐ．２５４５-２５４８ *
JPN6013008219; Ｃｙｎｔｈｉａ　Ｌ．　Ｓｕｎｄｅｌｌ　ｅｔ　ａｌ: Ｔｈｅ　Ｊｏｕｒｎａｌ　ｏｆ　Ｐｈａｒｍａｃｏｌｏｇｙ　ａｎｄ　Ｅｘｐｅｒｉｍｅｎｔａｌ　Ｔｈｅｒａｐｅｕｔｉｃｓ ３０５（３）, 200306, ｐ．１１１６-１１２３ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021512879A (ja) * 2018-01-30 2021-05-20 デモテック．インコーポレイテッド プロブコール誘導体及びその調製方法と使用
JP7146159B2 (ja) 2018-01-30 2022-10-04 デモテック．インコーポレイテッド プロブコール誘導体及びその調製方法と使用

Also Published As

Publication number Publication date
US20080280979A1 (en) 2008-11-13
EP2139320A1 (en) 2010-01-06
BRPI0809423A2 (pt) 2014-09-09
CA2682258A1 (en) 2008-10-02
CN101686676A (zh) 2010-03-31
IL201119A0 (en) 2010-05-17
US20120295973A1 (en) 2012-11-22
AU2008230861A1 (en) 2008-10-02
WO2008118948A1 (en) 2008-10-02
US8252840B2 (en) 2012-08-28
EP2139320A4 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
KR20120016051A (ko) 제약 조성물
CN1960735B (zh) 药物组合在治疗胰岛素抗性中的应用
EP3880187A1 (en) Treatment of obesity and its complications
KR20160136451A (ko) Nafld 및 nash 의 치료
AU2011356584B2 (en) Compounds and pharmaceutical compositions for uses in diabetes
KR20130137628A (ko) 대사 장애를 치료하기 위한 약제학적 병용물
CN113301889A (zh) Nafld和nash的联合治疗
US20120295973A1 (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
WO2006094933A1 (en) Roflumilast for the treatment of diabetes mellitus
JP2015523382A (ja) メトホルミンの三塩形態
WO2014008374A2 (en) Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents
CN1777417B (zh) PPARα激动剂和二甲双胍降低血清甘油三酯的用途
WO2016054726A1 (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
MX2012011517A (es) El uso de diacereina como una terapia adyuvante para diabetes.
BRPI0707670A2 (pt) composiÇço farmacÊutica, e, uso de um composto meglitinida
US20080280985A1 (en) Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes
KR20150023405A (ko) 간 기능 개선 방법
WO2005092349A1 (ja) インスリン抵抗性改善剤
HK1142773A (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
WO2017126524A1 (ja) 糖尿病治療剤の併用
BRPI0721333A2 (pt) Composição útil para o tratamento de diabetes tipo 2
JP4914714B2 (ja) 脂質代謝異常の予防または治療用医薬組成物
ES2359910T3 (es) Composición medicinal para inhibir la expresión de atp-citrato liasa y su uso.
WO2010039040A1 (en) Composition comprising a ppar agonist and a phospholipid component
MXPA05004450A (en) Combination of an antidiabetic agent with an antiobesity agent useful for treating and preventing diabetes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120307

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130226

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20130305

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130508

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130515

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130917